| Entry |
|
|---|
| Name |
Xamoterol (USAN) |
|---|
| Formula |
C16H25N3O5
|
|---|
| Exact mass |
339.1794
|
|---|
| Mol weight |
339.3868
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Cardiovascular agent
DG01703 Cardiotonic
|
|---|
| Remark |
|
|---|
| Efficacy |
Cardiotonic, beta1-Adrenergic receptor partial agonist |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
| hsa04261 | Adrenergic signaling in cardiomyocytes |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C01 CARDIAC THERAPY
C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01CX Other cardiac stimulants
C01CX07 Xamoterol
D06328 Xamoterol (USAN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01703 Cardiotonic
DG00231 Xamoterol
D06328 Xamoterol
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRB1
D06328 Xamoterol (USAN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01703 Cardiotonic
DG00231 Xamoterol
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 24
1 C1b C 27.3243 -18.5092
2 N1b N 28.5385 -17.8088
3 C5a C 29.7468 -18.4975
4 N1y N 30.9608 -17.8030
5 C1x C 32.1691 -18.4975
6 C1x C 30.9608 -16.4021
7 C1x C 33.3831 -17.8030
8 C1x C 32.1691 -15.6959
9 O2x O 33.3831 -16.4021
10 O5a O 29.7479 -19.8800
11 C1b C 26.0811 -17.7913
12 N1b N 24.8952 -18.4759
13 C1b C 23.7033 -17.7874
14 C1c C 22.5141 -18.4739
15 C1b C 21.3239 -17.7865
16 O1a O 22.5138 -19.8798
17 O2a O 20.1338 -18.4734
18 C8y C 18.9440 -17.7862
19 C8x C 18.9441 -16.3802
20 C8x C 17.7318 -15.6801
21 C8y C 16.5193 -16.3800
22 C8x C 16.5191 -17.7860
23 C8x C 17.7315 -18.4861
24 O1a O 15.3075 -15.6802
BOND 25
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 4 6 1
6 5 7 1
7 6 8 1
8 7 9 1
9 8 9 1
10 3 10 2
11 1 11 1
12 11 12 1
13 12 13 1
14 13 14 1
15 14 15 1
16 14 16 1
17 15 17 1
18 17 18 1
19 18 19 2
20 19 20 1
21 20 21 2
22 21 22 1
23 22 23 2
24 18 23 1
25 21 24 1
|
|---|
